Selected research
Market Structure
Global RNA Transcriptome Profiling Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global RNA Transcriptome Profiling Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of RNA Transcriptome Profiling Test include Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Merck KGaA, Eurofins Scientific and Pacific Biosciences of California, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global RNA Transcriptome Profiling Test market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of RNA Transcriptome Profiling Test and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents RNA Transcriptome Profiling Test revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the RNA Transcriptome Profiling Test market size, projected growth trends, production technologies, key applications, and end-use industries.
RNA Transcriptome Profiling Test Segment by Company
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Agilent Technologies, Inc.
QIAGEN N.V.
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc.
Merck KGaA
Eurofins Scientific
Pacific Biosciences of California, Inc.
Promega Corporation
10x Genomics
Twist Bioscience
Bruker Spatial Biology
RNA Transcriptome Profiling Test Segment by Type
Consumables
Instruments
Software
Services
RNA Transcriptome Profiling Test Segment by Application
Hospital Based Laboratories
Diagnostic Centers
Academic and Research Institutes
Contract research Organizations (CROs)
Others
RNA Transcriptome Profiling Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Transcriptome Profiling Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of RNA Transcriptome Profiling Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Transcriptome Profiling Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of RNA Transcriptome Profiling Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RNA Transcriptome Profiling Test industry.
Chapter 3: Detailed analysis of RNA Transcriptome Profiling Test companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RNA Transcriptome Profiling Testrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Consumables
- Instruments
- Software
- Services
Applications
- Hospital Based Laboratories
- Diagnostic Centers
- Academic and Research Institutes
- Contract research Organizations (CROs)
- Others
Companies covered
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- QIAGEN N.V.
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Eurofins Scientific
- Pacific Biosciences of California, Inc.
- Promega Corporation
- 10x Genomics
- Twist Bioscience
- Bruker Spatial Biology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global RNA Transcriptome Profiling Test Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Consumables
- 1.2.3 Instruments
- 1.2.4 Software
- 1.2.5 Services
- 1.3 Market Analysis by Application
- 1.3.1 Global RNA Transcriptome Profiling Test Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital Based Laboratories
- 1.3.3 Diagnostic Centers
- 1.3.4 Academic and Research Institutes
- 1.3.5 Contract research Organizations (CROs)
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global RNA Transcriptome Profiling Test Growth Trends by Region
- 1.5.1 Global RNA Transcriptome Profiling Test Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 RNA Transcriptome Profiling Test Market Size by Region (2021-2026)
- 1.5.3 RNA Transcriptome Profiling Test Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global RNA Transcriptome Profiling Test Market Dynamics
- 2.1 RNA Transcriptome Profiling Test Industry Trends
- 2.2 RNA Transcriptome Profiling Test Industry Drivers
- 2.3 RNA Transcriptome Profiling Test Industry Opportunities and Challenges
- 2.4 RNA Transcriptome Profiling Test Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global RNA Transcriptome Profiling Test Revenue by Company (2021-2026)
- 3.2 Global RNA Transcriptome Profiling Test Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global RNA Transcriptome Profiling Test Key Company Head office and Area Served
- 3.4 Global RNA Transcriptome Profiling Test Company, Product Type & Application
- 3.5 Global RNA Transcriptome Profiling Test Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global RNA Transcriptome Profiling Test Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 RNA Transcriptome Profiling Test Players Market Share by Revenue in 2025
- 3.6.3 2025 RNA Transcriptome Profiling Test Tier 1, Tier 2, and Tier 3
4 RNA Transcriptome Profiling Test Market by Type
- 4.1 Global RNA Transcriptome Profiling Test Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global RNA Transcriptome Profiling Test Market Size by Type (2021-2032)
- 4.3 Global RNA Transcriptome Profiling Test Market Size Share by Type (2021-2032)
5 RNA Transcriptome Profiling Test Market by Application
- 5.1 Global RNA Transcriptome Profiling Test Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global RNA Transcriptome Profiling Test Market Size by Application (2021-2032)
- 5.3 Global RNA Transcriptome Profiling Test Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher Scientific, Inc.
- 6.1.1 Thermo Fisher Scientific, Inc. Company Information
- 6.1.2 Thermo Fisher Scientific, Inc. Business Overview
- 6.1.3 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 6.1.5 Thermo Fisher Scientific, Inc. Recent Developments
- 6.2 Illumina, Inc.
- 6.2.1 Illumina, Inc. Company Information
- 6.2.2 Illumina, Inc. Business Overview
- 6.2.3 Illumina, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 6.2.5 Illumina, Inc. Recent Developments
- 6.3 Agilent Technologies, Inc.
- 6.3.1 Agilent Technologies, Inc. Company Information
- 6.3.2 Agilent Technologies, Inc. Business Overview
- 6.3.3 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 6.3.5 Agilent Technologies, Inc. Recent Developments
- 6.4 QIAGEN N.V.
- 6.4.1 QIAGEN N.V. Company Information
- 6.4.2 QIAGEN N.V. Business Overview
- 6.4.3 QIAGEN N.V. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio
- 6.4.5 QIAGEN N.V. Recent Developments
- 6.5 F. Hoffmann-La Roche AG
- 6.5.1 F. Hoffmann-La Roche AG Company Information
- 6.5.2 F. Hoffmann-La Roche AG Business Overview
- 6.5.3 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio
- 6.5.5 F. Hoffmann-La Roche AG Recent Developments
- 6.6 Bio-Rad Laboratories, Inc.
- 6.6.1 Bio-Rad Laboratories, Inc. Company Information
- 6.6.2 Bio-Rad Laboratories, Inc. Business Overview
- 6.6.3 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 6.6.5 Bio-Rad Laboratories, Inc. Recent Developments
- 6.7 Merck KGaA
- 6.7.1 Merck KGaA Company Information
- 6.7.2 Merck KGaA Business Overview
- 6.7.3 Merck KGaA RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Merck KGaA RNA Transcriptome Profiling Test Product Portfolio
- 6.7.5 Merck KGaA Recent Developments
- 6.8 Eurofins Scientific
- 6.8.1 Eurofins Scientific Company Information
- 6.8.2 Eurofins Scientific Business Overview
- 6.8.3 Eurofins Scientific RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio
- 6.8.5 Eurofins Scientific Recent Developments
- 6.9 Pacific Biosciences of California, Inc.
- 6.9.1 Pacific Biosciences of California, Inc. Company Information
- 6.9.2 Pacific Biosciences of California, Inc. Business Overview
- 6.9.3 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio
- 6.9.5 Pacific Biosciences of California, Inc. Recent Developments
- 6.10 Promega Corporation
- 6.10.1 Promega Corporation Company Information
- 6.10.2 Promega Corporation Business Overview
- 6.10.3 Promega Corporation RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Promega Corporation RNA Transcriptome Profiling Test Product Portfolio
- 6.10.5 Promega Corporation Recent Developments
- 6.11 10x Genomics
- 6.11.1 10x Genomics Company Information
- 6.11.2 10x Genomics Business Overview
- 6.11.3 10x Genomics RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 10x Genomics RNA Transcriptome Profiling Test Product Portfolio
- 6.11.5 10x Genomics Recent Developments
- 6.12 Twist Bioscience
- 6.12.1 Twist Bioscience Company Information
- 6.12.2 Twist Bioscience Business Overview
- 6.12.3 Twist Bioscience RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio
- 6.12.5 Twist Bioscience Recent Developments
- 6.13 Bruker Spatial Biology
- 6.13.1 Bruker Spatial Biology Company Information
- 6.13.2 Bruker Spatial Biology Business Overview
- 6.13.3 Bruker Spatial Biology RNA Transcriptome Profiling Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio
- 6.13.5 Bruker Spatial Biology Recent Developments
7 North America
- 7.1 North America RNA Transcriptome Profiling Test Market Size (2021-2032)
- 7.2 North America RNA Transcriptome Profiling Test Market Size by Type
- 7.2.1 North America RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
- 7.2.2 North America RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
- 7.2.3 North America RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
- 7.3 North America RNA Transcriptome Profiling Test Market Size by Application
- 7.3.1 North America RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
- 7.3.2 North America RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
- 7.3.3 North America RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
- 7.4 North America RNA Transcriptome Profiling Test Market Size by Country
- 7.4.1 North America RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 7.4.3 North America RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 7.4.4 North America RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe RNA Transcriptome Profiling Test Market Size (2021-2032)
- 8.2 Europe RNA Transcriptome Profiling Test Market Size by Type
- 8.2.1 Europe RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
- 8.2.2 Europe RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
- 8.2.3 Europe RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
- 8.3 Europe RNA Transcriptome Profiling Test Market Size by Application
- 8.3.1 Europe RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
- 8.3.2 Europe RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
- 8.3.3 Europe RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
- 8.4 Europe RNA Transcriptome Profiling Test Market Size by Country
- 8.4.1 Europe RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 8.4.3 Europe RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 8.4.4 Europe RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China RNA Transcriptome Profiling Test Market Size (2021-2032)
- 9.2 China RNA Transcriptome Profiling Test Market Size by Type
- 9.2.1 China RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
- 9.2.2 China RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
- 9.2.3 China RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
- 9.3 China RNA Transcriptome Profiling Test Market Size by Application
- 9.3.1 China RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
- 9.3.2 China RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
- 9.3.3 China RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia RNA Transcriptome Profiling Test Market Size (2021-2032)
- 10.2 Asia RNA Transcriptome Profiling Test Market Size by Type
- 10.2.1 Asia RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
- 10.2.2 Asia RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
- 10.2.3 Asia RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
- 10.3 Asia RNA Transcriptome Profiling Test Market Size by Application
- 10.3.1 Asia RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
- 10.3.2 Asia RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
- 10.3.3 Asia RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
- 10.4 Asia RNA Transcriptome Profiling Test Market Size by Country
- 10.4.1 Asia RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 10.4.3 Asia RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 10.4.4 Asia RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size (2021-2032)
- 11.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type
- 11.2.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application
- 11.3.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country
- 11.4.1 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa RNA Transcriptome Profiling Test Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst